Alla inlägg om "placebo"
Research News16 January, 2014 by David FinerHomeopathy is generally superior to placebo, particularly in immune-related conditions. But it has been discounted by ideologically biased researchers, who have excluded almost all published studies, referring to virtual data, and using inappropriate statistics, writes physician Robert Hahn in a critical analysis in Forschende Komplementärmedizin. Read more 
Tags: alternative medicine, bias, CAM, CI, communication, confidence interval, conflict, controversy, David Finer, Edzard Ernst, evidence, Forschende Komplementärmedizin, homeopathy, ideology, odds ratio, OR, placebo, randomized controlled trial, RCT, review, Robert Hahn
Policy News13 September, 2013 by David FinerComplementary and alternative medicine slips through the cracks of the government agencies, and consumers have to pay. That is why there is a need for sceptics´and consumer organizations. Molecular cell biologist Professor Dan Larhammar, Uppsala University focused on ineffective and fraudulent alternatives in a lecture on the eve of the 15th European Sceptics Congress in Stockholm recently. Read more
Tags: 15th European Skeptics Congress, Almedalen, alternative medicine, bluff, BMC Complementary and Alternative Medicine, CAM, Christer Fuglesang, Christopher Hitchens, Dan Larhammar, David Finer, dissidents, Edzard Ernst, ethics, European Union, evidence, homeopathy, Integrative Care Science Center, marketing, mobbing, National Board of Health and Welfare, Nobel Prize, Olof Palme, Osher Center for Integrative Medicine, persecution, PJ Råsmark, placebo, Police, pseudoscience, Simon Singh, Swedish Food Agency, Swedish Skeptics Association, Trick or Treatment, Vetenskap och Folkbildning, VoF
Policy News31 May, 2013 by Johanna HökFor three days in April 2013, 500 researchers from all over the world gathered in London for the 8th international congress on complementary and alternative medicine research (ICCMR). As a participant and co-organiser, I C’s Johanna Hök reflects about the congress and it’s contributions including some of her favourite examples of research: a study on […] Read more
Tags: Brian Berman, CAM, Cochrane, David Eisenberg, diet, Felicity Bishop, George Lewith, Holger Cramer, ICCMR 2013, Jeremy Howick, Johanna Hök, low back pain, manual therapy, Michael Hyland, NICE, nutrition, pain, patient experience, patient-provider relationship, placebo, Samueli Institute, yoga
Research News23 February, 2013 by David FinerAcupuncture has a specific effect on chronic pain, superior to both no-acupuncture control and sham acupuncture. A review in JAMA of some 18 000 patients finds acupuncture is a reasonable referral option for patients with chronic pain. Read more
Tags: acupuncture, back pain, CAM, chronic pain, George Lewith, headache, meta-analysis, neck pain, osteoarthritis, placebo, RCT, sham acupuncture, shoulder pain
Research News30 October, 2012 by David FinerA study on participants in clinical trials (“human guinea pigs”) challenges the basic assumption that one can distinguish specific from non-specific treatment effects. It also shows that curiosity, altruism and status-seeking are part of the reason why people take part in clinical trials. Read more
Tags: acupuncture, CAM, choice, clinical trial, communication, David Finer, ECIM, George Lewith, Health Technology Assessment, meaning, orthodox medicine, participation, patient-doctor communication, placebo, treatment effect
Research News18 September, 2012 by Johanna HökDownward spiraling emotions typical of affective disorders may be lastingly offset by recourse to ”loving kindness”-meditation. IC´s reporter Johanna Hök took part in the seventh international CAM research conference in Portland, Oregon. Read more
Tags: acupuncture, anxiety, CAM, Claudia Witt, communication, David Eisenberg, disease, emotion, Harvard, I C, illness, Integrative Care Science Center, Johanna Hök, loving kindness, lumbar pain, meditation, narrative, nocebo, Osher, pain, patient-doctor communication, placebo, schizophrenia
